Clinical trial
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
NCT00474669 · University of Louisville, Other · Completed
Key facts
| NCT number | NCT00474669 |
|---|---|
| Title | A Phase I Study of Intraperitoneal Hyperthermic Docetaxel |
| Official title | A Phase I Study of Intraperitoneal Hyperthermic Docetaxel at the Time of Second Look Surgery Following Front-Line Normothermic Intraperitoneal and Intravenous Cisplatin/Paclitaxel for Patients With Stage II and III Ovarian Carcinoma |
| Acronym | IP |
| Lead sponsor | University of Louisville, Other |
| Collaborators | James Graham Brown Cancer Center |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Carcinoma |
| Intervention type | Drug |
| Interventions | docetaxel |
| Enrollment | 30 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | May 17, 2007 |
| Last update posted | Jan 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: